FDA Approves New AndroGel Formulation

Share this article:

The FDA has approved Abbott's AndroGel 1.62%, a testosterone gel that restores levels of the hormone in hypogonadal men with half the volume of gel at the starting dose than delivered in AndroGel 1%.

The newly approved formulation contains 40.5 mg of testosterone in two pump presses, compared with the 1% gel's 50 mg in four pump presses.

With different dosage and administration instructions, the two gels are not interchangeable.

Share this article:
You must be a registered member of RUN to post a comment.

More in Hypogonadism

Hypogonadism May Raise Death Risk in Men with CKD

Hypogonadism May Raise Death Risk in Men with ...

Patients in the second lowest quintile of testosterone level had a 53% increased death risk compared with those in the highest quintile.

High Estradiol Boosts Libido in Men on Testosterone Therapy

High Estradiol Boosts Libido in Men on Testosterone ...

Elevated serum estradiol is associated with increased libido in men receiving TST.

FDA to Review Testosterone Therapy Safety

FDA to Review Testosterone Therapy Safety

Agency pointed to recent studies citing possible heightened heart risk tied to the treatments.